Skip to main content
Equibles

DAFNA Capital Management LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1389933 LOS ANGELES, CA
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,736,387
+$433,567 QoQ
Shares Held
57,769
-18.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#160
of 775 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $22,367,669 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (43.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page 		57,769 $9,736,387
2 ALKS
Alkermes plc.
 101,266 $5,306,338
3 BCRX
Biocryst Pharmaceuticals Inc
 400,248 $4,002,480
4 AQST
Aquestive Therapeutics, Inc.
 645,915 $2,687,006
5 SCYX
Scynexis Inc
 135,868 $552,982
6 ADCT
ADC Therapeutics SA
 77,081 $82,476

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,736,387 57,769
2026-03-31 $9,302,820 70,615
2025-12-31 $10,015,325 70,615
2025-09-30 $9,912,933 70,615
2025-06-30 $8,875,599 70,615
2025-03-31 $7,920,619 71,615
2024-12-31 $9,775,447 71,615
2024-09-30 $8,021,040 69,615
2024-06-30 $9,859,237 71,615
2024-03-31 $9,877,140 71,615
2023-12-31 $9,567,752 72,615
2023-09-30 $8,281,687 73,615
2023-06-30 $7,036,194 74,615
2023-03-31 $7,552,530 74,615
2022-12-31 $8,733,572 73,121
2022-09-30 $8,513,262 80,155
2022-06-30 $8,057,209 82,655
2022-03-31 $7,842,656 83,655
2021-12-31 $7,124,896 83,655
2021-09-30 $8,119,261 84,655
2021-06-30 $7,168,104 73,655
2021-03-31 $7,162,948 73,655
2020-12-31 $8,838,136 92,208
2020-09-30 $8,674,401 90,208
2020-06-30 $8,931,376 73,208
2020-03-31 $6,942,002 80,208